The FDA-approved technology developed by HeartFlow can predict a patient's long-term risk of target vessel failure as well as more invasive treatments performed inside a cath lab. 

Buzzworthy developments of the past few days.

Years will pass before the global economy’s healthcare sector sufficiently leverages AI to build major financial muscle off of it. And even then, industry players are likely to see gains well ahead of hospitals and health systems. 

Leslee J. Shaw, PhD, and Martha Gulati, MD, are joining forces to discuss how CAD presents in women, advances in imaging technology and much more. 

The White House held a roundtable discussion on lowering healthcare costs last week. Fortune magazine followed up with one of the panelists, business mogul and Cost Plus Drugs cofounder Mark Cuban.

Have hospitals really taken a step backward along their march toward price transparency? Or is the watchdog outfit making the claim playing fast and loose with the facts?

The FDA made a special announcement about its decision, describing the news as "a major advance for public health."

“This is what happens when everything merges and you only have one option.”